Michael E Wechsler Selected Research

Nasopharyngitis

11/2021	Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial.
5/2015	Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael E Wechsler Research Topics

Disease

147	Asthma (Bronchial Asthma) 05/2024 - 01/2002
20	Inflammation (Inflammations) 02/2024 - 04/2007
19	Churg-Strauss Syndrome (Allergic Angiitis) 02/2024 - 01/2002
10	Vasculitis (Vasculitides) 01/2024 - 01/2002
9	Eosinophilia 12/2023 - 08/2007
8	Chronic Obstructive Pulmonary Disease (COPD) 09/2023 - 10/2010
5	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2023 - 06/2006
5	Respiratory Hypersensitivity 11/2021 - 07/2008
4	Infections 11/2023 - 02/2011
4	Lung Diseases (Lung Disease) 09/2023 - 08/2007
3	Atopic Dermatitis (Atopic Eczema) 11/2023 - 10/2021
3	Nasal Polyps (Nasal Polyp) 11/2023 - 01/2021
3	Rhinosinusitis 11/2023 - 01/2022
3	Hypersensitivity (Allergy) 02/2022 - 01/2015
3	Respiratory Tract Infections (Respiratory Tract Infection) 11/2021 - 05/2015
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 11/2021 - 03/2006
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2023 - 01/2023
2	Obesity 08/2023 - 01/2019
2	Glomerulonephritis 07/2023 - 01/2017
2	Airway Remodeling 11/2021 - 10/2020
2	Nasopharyngitis 11/2021 - 05/2015
2	Sinusitis 01/2021 - 01/2002
2	COVID-19 01/2021 - 10/2020
2	Coronavirus Infections 10/2020 - 04/2020
2	Septic Shock (Toxic Shock Syndrome) 03/2006 - 09/2005
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2024
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2024
1	Retinal Vein Occlusion 01/2024
1	Retinal Artery Occlusion 01/2024

Drug/Important Bio-Agent (IBA)

67	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 01/2002
20	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2007
14	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2024 - 07/2003
12	GlucocorticoidsIBA 01/2023 - 10/2010
11	mepolizumabIBA 02/2024 - 06/2010
10	tezepelumabIBA 04/2024 - 10/2020
10	Interleukin-5 (Interleukin 5)IBA 01/2024 - 11/2014
10	dupilumabIBA 11/2023 - 10/2021
10	SteroidsIBA 01/2023 - 01/2007
9	Monoclonal AntibodiesIBA 11/2021 - 01/2017
8	Bronchodilator Agents (Bronchodilators)IBA 04/2024 - 04/2005
8	Interleukin-13IBA 01/2023 - 06/2013
8	Albuterol (Salbutamol)FDA LinkGeneric 10/2022 - 10/2004
7	Immunoglobulin E (IgE)IBA 01/2023 - 03/2008
7	CytokinesIBA 01/2022 - 03/2017
7	Tiotropium Bromide (Spiriva)FDA Link 01/2022 - 10/2010
7	Salmeterol Xinafoate (Serevent)FDA Link 01/2019 - 04/2005
7	LeukotrienesIBA 01/2014 - 01/2002
6	benralizumabIBA 02/2024 - 10/2018
6	reslizumabIBA 01/2022 - 05/2015
6	Methacholine Chloride (Methacholine)FDA Link 01/2017 - 04/2005
5	Muscarinic AntagonistsIBA 02/2024 - 01/2019
5	anti-IgE antibodiesIBA 12/2023 - 09/2015
5	Fluticasone (Cutivate)FDA LinkGeneric 12/2021 - 10/2010
5	Interleukin-4 (Interleukin 4)IBA 10/2021 - 06/2013
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2023 - 01/2017
4	Thymic Stromal LymphopoietinIBA 01/2023 - 06/2018
4	Omalizumab (Xolair)FDA Link 01/2022 - 08/2009
4	Vitamin D FDA LinkGeneric 10/2018 - 05/2014
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2020
3	VaccinesIBA 09/2023 - 02/2022
3	InterleukinsIBA 01/2023 - 11/2014
3	Beclomethasone (Beclometasone)FDA Link 01/2022 - 02/2007
3	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2022 - 01/2018
3	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2021 - 02/2007
3	Cholecalciferol (Vitamin D3)FDA Link 10/2018 - 05/2014
3	Cholinergic Antagonists (Anticholinergics)IBA 10/2015 - 10/2010
3	lipoxin A4IBA 10/2014 - 02/2013
2	AntigensIBA 09/2023 - 01/2023
2	COVID-19 VaccinesIBA 09/2023 - 01/2023
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 01/2021
2	mRNA VaccinesIBA 01/2023 - 01/2022
2	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2022 - 01/2019
2	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2021 - 01/2019
2	itepekimabIBA 11/2021 - 10/2021
2	Interleukin-33IBA 11/2021 - 10/2021
2	InterferonsIBA 10/2020 - 04/2020
2	Interleukin-6 (Interleukin 6)IBA 10/2020 - 04/2020
2	Interleukin-17 (Interleukin 17)IBA 06/2018 - 11/2014
2	16S Ribosomal RNAIBA 01/2018 - 07/2017
2	Amino Acids FDA Link 07/2017 - 11/2009
2	SmokeIBA 01/2016 - 04/2007
2	LipoxinsIBA 10/2014 - 09/2013
2	salicylhydroxamic acid (SHAM)IBA 07/2011 - 01/2010
2	Clarithromycin (Biaxin)FDA LinkGeneric 02/2011 - 10/2010
2	Arginine (L-Arginine)FDA Link 11/2009 - 03/2006
2	arginylarginine (Arg-Arg)IBA 11/2009 - 10/2004
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2009 - 03/2006
2	montelukast (Singulair)FDA Link 04/2007 - 02/2007
1	GSK573719IBA 02/2024
1	vilanterolIBA 02/2024
1	fluticasone furoate FDA Link 02/2024
1	Retinaldehyde (Retinal)IBA 01/2024
1	PeriostinIBA 12/2023

Therapy/Procedure

72	Therapeutics 02/2024 - 01/2002
10	Biological Therapy 03/2024 - 03/2017
8	Nebulizers and Vaporizers (Inhaler) 11/2023 - 07/2011
7	Bronchial Thermoplasty 12/2023 - 07/2008
5	Precision Medicine 01/2022 - 08/2013
2	Ambulatory Care (Outpatient Care) 11/2023 - 11/2022
2	Drug Tapering 10/2020 - 03/2016